Adjuvance Technologies Inc. — Form D/A
Adjuvance Technologies Inc. of Lincoln, NE, a company, filed a Form D amendment with the SEC on 2016-11-14. The offering totals $7.0M, of which $2.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-11-14
- Form: D/A
- Accession: 0001652786-16-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $2.7M
- Remaining: $4.3M
- Minimum investment: $25K
- Investors: 15
- Date of first sale: 2015-08-06
- Security types: debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-248000
Issuer
- Name: Adjuvance Technologies Inc.
- CIK: 0001652786
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1225 L Street, Suite 600, Lincoln, NE, 68508
- Phone: 4028175050
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| John Gallo | Director | New York, NY |
| Mary Gin | Director | Pelham, NY |
| Phil Livingston | Director | New York, NY |
| Gregory Poland | Director | Rochester, MN |
| Christopher Frigon | Executive Officer | New York, NY |
| Jeffrey Gardner | Executive Officer | Littleton, CO |
| Isaac Cheng | Director | Portland, ME |
| Ken Kelley | Director | Lincoln, NE |
| Stephen Dilly | Director | Lincoln, NE |
| J. Tyler Martin | Director | Lincoln, NE |
| J. Tyler Martin | Executive Officer | Lincoln, NE |
| Tyler Martin | Director | Lincoln, NV |
| Tyler Martin | Executive Officer | Lincoln, NV |
| Jeffrey Gardner | Director | Littleton, CO |
| Christopher Frigon | Director | New York, NY |
| Govind Ragupathi | Director | New York, NY |
Other filings by this issuer (3)
More